期刊文献+

吉西他滨联合奥沙利铂对复发性卵巢癌的治疗价值分析 被引量:2

下载PDF
导出
摘要 目的探究吉西他滨联合奥沙利铂治疗复发性卵巢癌的价值。方法 50例复发性卵巢癌患者,随机分为观察组和对照组,各25例。观察组采用吉西他滨联合奥沙利铂治疗,对照组单独应用奥沙利铂治疗,比较两组患者的治疗效果和不良反应。结果观察组患者治疗总有效率为80%,高于对照组的52%(P<0.05);观察组不良反应发生率为4%,少于对照组的24%(P<0.05)。结论复发性卵巢癌患者,采用吉西他滨联合奥沙利铂的治疗方案具有更好的治疗效果,且不良反应少。
出处 《中国实用医药》 2016年第23期126-127,共2页 China Practical Medicine
  • 相关文献

参考文献3

二级参考文献21

  • 1黄海欣,李桂生.吉西他滨联合奥沙利铂治疗晚期复发上皮性卵巢癌[J].中国癌症杂志,2006,16(8):683-684. 被引量:5
  • 2Daly MB, Ozols RF.Symptoms of ovarian cancer where to set the bar?[J], JAMA, 2005,291 (22) : 2755.
  • 3Parmar MK,Ledermann JA, Colombo N,et al. Paclitaxel plus plat- inum-based chemotherapy versus conventional platinum-based che- motherapy in women with relapsed ovarian cancer: the ICON4/AGO2 OVAR-2 2 trial[J].Lancet, 2006,361 (9375) : 2099.
  • 4Keldsen N, Havsteen H, Vergote I, et al. Ahretamine (hexamethylme- lamine) in the treatment of p latinum-resistant ovarian cancer:a phase Ⅱ study[J].Gynecol Oncol, 2007,88(2) : 118.
  • 5Fracasso PM, Blessing JA,Morgan MA,et al. Phase II study of oxali- platin in platinum-resistant and refractory ovarian cancer: a Gyneco- logic Oncology Group study[J].J Clin Oncol,2005,21(14):2856.
  • 6Tay SK, Ilanchadran A,Tan TY,et al.First-line gemcitabine and carboplatin in advanced ovarian carcinoma:a phase Ⅱ study[J].BJOG, 2007,113(12): 1388.
  • 7Harnett P,Buck M, Beale P,et al. Phase lI study of gemcitabine and oxalip -latin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study[J].Int J Gy- necol Cancer,2007,17 (2):359.
  • 8Kalykaki A, Papakotoulas P,Tsousis S, et al.Gemcitabine plus ox- alip- latin(GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase Ⅱ study of the Hellenic Oncology Re- search Group (HORG)[J].Anticancer Res,2008,28:495.
  • 9Aghajanian C, Goff B, Nycum LR, et al. Independent radiologic review:bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer [ J]. Gynecol Oneol, 2014, 133:105-110.
  • 10Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine [ J ]. N Engl J Med, 2013, 369 : 1691-1703.

共引文献15

同被引文献29

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部